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Introduction. Lysosomal storage disorders (LSDs) are rare diseases with more than 50 different entities described today. The
spectrum of phenotypes varies from severe to lethal and early-onset disease to mild and late onset. Recognition of the clinical
signs and diagnostic workup is challenging and requires expertise. Diagnosis relies on finding abnormal metabolites in urine and
serum followed by further enzymatic or molecular analysis. Routine histological examination of the foetal and placental tissues
frequently shows vacuolisation, providing a readily available important clue to the diagnosis. Case Report. A third child of
consanguineal parents showed several dysmorphic features and a complicated neonatal period with eventual demise in the early
postneonatal period due to respiratory failure. An LSD was suspected based on clinical presentation, urine metabolite excretion,
skeletal radiograph, and vacuolisation in lymphocytes and placental tissues on, respectively, blood smear and routine
histological examination. Homozygosity mapping favoured galactosialidosis. The diagnosis was confirmed by massive parallel
sequencing, revealing a single nucleotide variation in the CTSA gene (c.265A>C, p.Ser89Arg). Discussion. Histological placental
examination may be either the first clue or complimentary evidence in recognizing LSDs. It is important to recognize these clues
as it may prompt further investigation and facilitate earlier recognition of the disease.
1. Introduction
Lysosomal storage disorders (LSDs) are a large and heterog-
enous group of congenital metabolic diseases. This group
consists of more than 50 different entities, each showing lyso-
somal accumulation of various undegraded metabolites in a
vast array of body tissues. The buildup of these metabolites
results in tissue malfunction, leading to multisystemic dis-
ease. The onset of symptoms is heterogenous, with some dis-
eases having an early and severe phenotype while others
appear to be mild, with symptoms appearing only later in life.
The different lysosomal storage disorders are rare, ranging
from 1 per 57,000 live births for Gaucher disease to 1 per
4.2 million live births for sialidosis. Although worldwide epi-
demiological data on LSDs is limited, as a group, the inci-
dence is estimated at around 1 : 5,000–1 : 8,000 [1].
The majority of LSDs are inherited in an autosomal
recessive fashion, while a couple (Fabry disease, Hunter syn-
drome, and Danon disease) are X-linked diseases. The cause
of metabolite accumulation is usually due to a defect in spe-
cific lysosomal enzymes or, less frequently, in nonenzymatic
lysosomal proteins or proteins involved in lysosomal biogen-
esis. In the past, these diseases were classified based on their
accumulated substrate(s). More recently, classification based
on the specific molecular defect is favoured, mainly due to a
growing understanding of the molecular basis of LSDs. This
classification helps to elucidate the mechanisms of lysosomal
storage malfunction and in some cases subdivides some LSDs
further by their distinctive faulty mechanism (e.g., sphingoli-
pidosis group that can owe their undegraded sphingolipid
accumulation to a defective enzyme or an activator protein
defect). Filocamo and Morrone discuss the classification,
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molecular basis, and laboratory findings of LSDs in more
detail [2].
The recognition of clinical features suggesting LSD
requires expertise, as the symptoms and other findings are
often unspecific and can be caused by defects in different
metabolic pathways or environmental factors. Even if an
LSD is suspected, the definitive diagnosis can still be chal-
lenging as the diagnostic tests differ for various groups of
lysosomal storage diseases. Preliminary tests on urine, serum,
or blood, in most cases identifying increased undegraded
metabolites, can assist in the diagnosis and in choosing the
appropriate enzymatic or molecular analysis.
Histologically, the accumulation of metabolites results in
vacuolisation of different tissues from the affected individual.
In severe early-onset LSDs, resulting in intrauterine foetal or
neonatal death, body tissue may not always be available for
further examination. Similar alterations can also be found
on histological examination of the placenta. This may help
steer the diagnosis towards LSDs as a group or sometimes
even suggest a specific LSD and thus facilitate or prompt fur-
ther investigations [3].
Individuals with galactosialidosis, the focus of our case
report, show a defective activity of two enzymes, b-
galactosidase (β-GAL) and neuraminidase 1 (NEU1). This
is caused by mutations in the CTSA gene, encoding lyso-
somal protective protein cathepsin A (PPCA). PPCA forms
a complex with β-GAL and NEU1 and carries out a protec-
tive function. The lack of PPCA results in a combined β-
GAL/NEU1 deficiency.
We report a case of galactosialidosis in which vacuolisa-
tion in placental tissues and lymphocytes, on, respectively,
routine histological examination and blood smear, instigated
further investigations which led to a definitive diagnosis.
2. Case Report
A third child of consanguineal parents showed multiple
dysmorphic features on routine prenatal sonography. The
foetus displayed facial abnormalities (retrognathia, protrud-
ing ears), deformed feet (sandal gap, club foot), polyhy-
dramnios, subcutaneous oedema, hydrocele, and ascites
(hydrops fetalis). Further prenatal diagnostic tests were
refused by the parents for religious reasons. The two other
children of the couple were in good health and showed no
congenital abnormalities.
At 37 weeks, 3 days from LMP, a baby boy was born. In
addition to the prenatal findings, generalized petechia
(mainly on the face) and a simian crease were observed.
The baby showed a high birthweight for gestational age
(3,680 g, >p90). Due to tachypnoea, continuous positive air-
way pressure was given over a short period of time, followed
by high airflow via the nasal cannula. A week after birth, pro-
gressive respiratory distress was seen with diffuse lung opac-
ities on chest radiograph. Further deterioration and a need
for intubation followed. An infectious agent was suspected
although cultures remained negative. The child died, just a
little more than a month after birth, due to respiratory failure.
Autopsy was refused by the parents.
During hospitalization, bloodwork showed anaemia,
thrombopenia, hypoalbuminemia, elevated liver enzymes
(alkaline phosphatase and γ-GT), and vacuolated lympho-
cytes. Urine analysis showed proteinuria and oligosacchari-
duria. Abdominal ultrasound demonstrated an enlarged
liver and spleen. The babygram findings were notable for
osteopenia, rough trabecular aspect of the bones, and meta-
physeal cupping and fraying.
The placenta was large and heavy (p95). Routine histolog-
ical examination revealed enlarged hydropic pale villi lined by
vacuolated syncytiotrophoblast and a foamy, vacuolated
appearance of villous stromal cells (Figures 1(a) and 1(b)).
Clinical findings suggested a severe, early-onset metabolic
disorder. Because of the blood smear findings (vacuolated
lymphocytes), urinalysis (oligosacchariduria), radiologic skel-
etal findings, and placental examination, a lysosomal storage
disease was suspected. The final differential diagnosis for this
clinical presentation, together with the first available labora-
tory tests, suggested either infantile sialidosis or galactosiali-
dosis. Homozygosity mapping favoured galactosialidosis.
This diagnosis was confirmed on a whole blood sample from
the infant by massive parallel sequencing with an LSD gene
(a) (b)
Figure 1: H&E section of the 3rd trimester placenta. An overview (a, original magnification ×4) shows pale enlarged villi with a distended pale
trophoblast layer and foamy appearance of the villous stromal cells. On higher magnification (b, original magnification ×20), coarse
vacuolisation in syncytiotrophoblast (thick arrow) and stromal cells (thin arrow) is observed.
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panel, finding a homozygous mutation in the CTSA gene
(c.265A>C, p.Ser89Arg).
The parents came in for genetic counselling and were
informed about the odds of recurrence (25%) in a future
pregnancy. As both parents wished to have another child, dif-
ferent precautionary measures such as chorionic villus sam-
pling and preimplantation diagnosis by way of in vitro
fertilization were discussed.
3. Discussion
Histological placental examination is a fast and low-cost
investigation that can be carried out in all surgical pathology
laboratories. It may prove to be a great tool in the workup of
complicated pregnancies, including but not limited to intra-
uterine death, perinatal death, intrauterine growth restric-
tion, and hydrops fetalis [4].
We present a case of hydrops fetalis where routine pla-
cental examination showed a heavy and large placenta for
gestational age. On histological examination, vacuolisation
in the syncytiotrophoblast and villous stromal cells was evi-
dent (Figures 1(a) and 1(b)). Coinciding finding of vacuo-
lated lymphocytes on blood smear motivated further
investigations that led to the diagnosis of galactosialidosis.
Since autopsy was refused by the parents, foetal tissues were
not available for examination.
Our findings of placental histology in galactosialidosis
were similar to ones previously reported in the literature [5].
Many LSDs may lead to nonimmune hydrops fetalis
(NIH). In a review by Gimovsky et al., LSDs accounted for
up to 5.2% of NIH and up to 17.4% if only idiopathic NIH
was considered [6]. Often, these cases are only recognized
as LSDs after recurrent pregnancies complicated by hydrops
fetalis [7, 8]. Any clues pointing towards metabolite storage
abnormalities may therefore be very helpful in achieving an
earlier diagnosis.
Additionally, paying attention to the distribution of
inclusions or vacuoles in different placental cells as well
as the type of vacuolisation may also be of help in further
steering of the diagnostic approach. Different LSDs seem to
have distinct cell populations in the placenta that are most
affected. For example, while galactosialidosis shows coarse
vacuolisation in the villous stroma and syncytiotrophoblast,
other LSDs only show vacuolisation in the stromal cells with-
out affecting the trophoblast (mucopolysaccharidosis), vacu-
oles in intermediate trophoblast (mucolipidosis type II), and
vacuolisation in Hofbauer cells (β-glucuronidase deficiency).
However, much overlap is seen. Benirschke et al.’s Pathology
of the Human Placenta provides a summary on placental his-
tology in LSDs [3].
Although the placenta is often enlarged or hydropic in
cases of LSD, vacuolisation or inclusions are not always evi-
dent [3]. A thorough examination of the placenta, especially
in cases with NIH, is therefore warranted.
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